News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,307 Results
Type
Article (87414)
Company Profile (739)
Press Release (770136)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (232769)
Career Advice (4143)
Deals (39873)
Drug Delivery (144)
Drug Development (91177)
Employer Resources (205)
FDA (18253)
Job Trends (17422)
News (396853)
Policy (39843)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3002)
Academic (1)
Accelerated approval (31)
Adcomms (30)
Allergies (120)
Alliances (56797)
ALS (153)
Alzheimer's disease (1749)
Antibody-drug conjugate (ADC) (312)
Approvals (18368)
Artificial intelligence (469)
Autoimmune disease (155)
Automation (31)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (457)
Bladder cancer (145)
Brain cancer (52)
Breast cancer (538)
Cancer (4276)
Cardiovascular disease (302)
Career advice (3568)
Career pathing (41)
CAR-T (289)
CDC (36)
Celiac Disease (1)
Cell therapy (760)
Cervical cancer (29)
Clinical research (76106)
Collaboration (1604)
Company closure (4)
Compensation (990)
Complete response letters (64)
COVID-19 (2927)
CRISPR (85)
C-suite (732)
Cystic fibrosis (143)
Data (5409)
Decentralized trials (2)
Denatured (73)
Depression (114)
Diabetes (341)
Diagnostics (6982)
Digital health (24)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (251)
Drug pricing (161)
Drug shortages (19)
Duchenne muscular dystrophy (197)
Earnings (97998)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (132800)
Executive appointments (824)
FDA (20621)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1269)
Gene editing (183)
Generative AI (46)
Gene therapy (601)
GLP-1 (932)
Government (5323)
Grass and pollen (4)
Guidances (276)
Healthcare (20779)
HIV (43)
Huntington's disease (46)
IgA nephropathy (79)
Immunology and inflammation (267)
Immuno-oncology (58)
Indications (82)
Infectious disease (3146)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (95)
Intellectual property (198)
Interviews (816)
IPO (17808)
IRA (45)
Job creations (5198)
Job search strategy (2866)
JPM (66)
Kidney cancer (16)
Labor market (92)
Layoffs (639)
Leadership (37)
Legal (10091)
Liver cancer (87)
Longevity (13)
Lung cancer (583)
Lymphoma (331)
Machine learning (41)
Management (66)
Manufacturing (715)
MASH (159)
Medical device (14423)
Medtech (14453)
Mergers & acquisitions (22742)
Metabolic disorders (1063)
Multiple sclerosis (149)
NASH (22)
Neurodegenerative disease (327)
Neuropsychiatric disorders (79)
Neuroscience (2891)
Neurotech (1)
NextGen: Class of 2026 (7686)
Non-profit (5079)
Now hiring (65)
Obesity (520)
Opinion (325)
Ovarian cancer (150)
Pain (154)
Pancreatic cancer (170)
Parkinson's disease (260)
Partnered (33)
Patents (395)
Patient recruitment (414)
Peanut (56)
People (66278)
Pharmaceutical (133)
Pharmacy benefit managers (20)
Phase 1 (23595)
Phase 2 (33119)
Phase 3 (24813)
Pipeline (4284)
Policy (283)
Postmarket research (3545)
Preclinical (10586)
Press Release (72)
Prostate cancer (203)
Psychedelics (51)
Radiopharmaceuticals (278)
Rare diseases (792)
Real estate (7422)
Recruiting (80)
Regulatory (28231)
Reports (64)
Research institute (2695)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (21)
RSV (63)
Schizophrenia (139)
Series A (224)
Series B (160)
Service/supplier (25)
Sickle cell disease (85)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4323)
State (2)
Stomach cancer (14)
Supply chain (74)
Tariffs (76)
The Weekly (122)
Vaccines (1000)
Venture capital (91)
Weight loss (338)
Women's health (71)
Worklife (22)
Date
Today (3)
Last 7 days (472)
Last 30 days (1739)
Last 365 days (25270)
2026 (2381)
2025 (25559)
2024 (34049)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (85)
Alaska (6)
Arizona (288)
Arkansas (8)
Asia (51121)
Australia (9002)
California (9722)
Canada (2474)
China (1055)
Colorado (309)
Connecticut (389)
Delaware (295)
Europe (116903)
Florida (1256)
Georgia (253)
Hawaii (4)
Idaho (65)
Illinois (652)
India (56)
Indiana (445)
Iowa (21)
Japan (338)
Kansas (133)
Kentucky (25)
Louisiana (14)
Maine (59)
Maryland (1261)
Massachusetts (7305)
Michigan (244)
Minnesota (453)
Mississippi (5)
Missouri (78)
Montana (28)
Nebraska (29)
Nevada (106)
New Hampshire (57)
New Jersey (2552)
New Mexico (29)
New York (2551)
North Carolina (1410)
North Dakota (9)
Northern California (4773)
Ohio (258)
Oklahoma (18)
Oregon (51)
Pennsylvania (1870)
Puerto Rico (22)
Rhode Island (33)
South America (1658)
South Carolina (14)
South Dakota (1)
Southern California (3750)
Tennessee (58)
Texas (1361)
United States (33803)
Utah (210)
Vermont (1)
Virginia (168)
Washington D.C. (54)
Washington State (818)
West Virginia (2)
Wisconsin (82)
858,307 Results for "epic bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
Congress Re-Introduces EPIC Act to Remove IRA’s ‘Pill Penalty’
While many industry players and observers have high hopes for the EPIC Act, some say budgetary headwinds could make it difficult for the current administration to make meaningful repeals or amendments to the IRA.
February 26, 2025
·
2 min read
·
Tristan Manalac
Biotech Bay
Epic Bio to Present IND-Enabling Data Package for EPI-321 at FSHD International Research Congress
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, announced its participation in the upcoming FSHD International Research Congress being held June 13-14, 2024, in Denver, Colo.
June 7, 2024
·
2 min read
Biotech Bay
Epic Bio to Participate in a Fireside Chat at the Canaccord Genuity Genetic Medicine for Generalists
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced that Amber Salzman, Ph.D., chief executive officer, participated in a fireside chat at the Canaccord Genuity - Genetic Medicine for Generalists Fireside Chat today.
April 10, 2024
·
1 min read
Press Releases
Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration
September 23, 2025
·
4 min read
Biotech Bay
Epic Bio to Participate in a Fireside Chat at the Cantor Virtual Muscular Dystrophy Symposium
Epic Bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that Amber Salzman, Ph.D., chief executive officer, will participate in a fireside chat at the Cantor Virtual Muscular Dystrophy Symposium at 9:40 a.m. PT, Tuesday, April 2, 2024.
April 1, 2024
·
1 min read
Biotech Bay
Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy Summit
Epic Bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that Amber Salzman, Ph.D., chief executive officer, will present at the Charles River Cell & Gene Therapy Summit at 2:00 p.m. PT, Tuesday, March 19, 2024, in South San Francisco, Calif.
March 13, 2024
·
1 min read
Biotech Bay
Epic Bio to Present at the Upcoming CRISPR2.0 Conference
Epic Bio announced a presentation at the upcoming CRISPR2.0 conference being held November 28-30, 2023, at the Hilton Boston Back Bay, Boston Massachusetts.
November 21, 2023
·
1 min read
Biotech Bay
Epic Bio to Participate in Upcoming November 2023 Investor Conference
Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, announced that the management will participate in an upcoming investor conference.
November 7, 2023
·
1 min read
Press Releases
Philips announces collaboration with Epic to enhance ambulatory cardiac monitoring
July 25, 2025
·
3 min read
Biotech Bay
Epic Bio Announces Robust Slate of Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced the acceptance of six abstracts, three oral presentations, and three poster presentations at the upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 7-11, 2024, in Baltimore, Maryland.
April 9, 2024
·
2 min read
1 of 85,831
Next
